Cargando…

Antiviral Strategies and Vaccines against HTLV III/LAV

Detalles Bibliográficos
Autor principal:	Dalgleish, A. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Physicians of London 1986
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371046/ https://www.ncbi.nlm.nih.gov/pubmed/2430099

Ejemplares similares

LAV 1 Installation
por: Antonelli, A
Publicado: (2008)

LAV Fabrication and Installation
por: Moulson, M, et al.
Publicado: (2011)

The NA62 LAV front-end electronics
por: Antonelli, A., et al.
Publicado: (2011)

The NA62 LAV front-end electronics and the L0 trigger generating firmware
por: Gonnella, Francesco, et al.
Publicado: (2014)

Integrating Controls Frameworks: Control Systems for NA62 LAV Detector Test Beams
por: Holme, Oliver, et al.
Publicado: (2011)

INTEGRATING CONTROLS FRAMEWORKS: CONTROL SYSTEMS FOR NA62 LAV DETECTOR TEST BEAMS
por: Holme, O, et al.
Publicado: (2011)

Effects of Human LAV-BPIFB4 Gene Therapy on the Epigenetic Clock and Health of Aged Mice
por: Giuliani, Maria Elisa, et al.
Publicado: (2023)

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)

LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice
por: Malavolta, Marco, et al.
Publicado: (2019)

The Lightweight Autonomous Vehicle Self-Diagnosis (LAVS) Using Machine Learning Based on Sensors and Multi-Protocol IoT Gateway
por: Jeong, YiNa, et al.
Publicado: (2019)

LAV-BPIFB4 isoform modulates eNOS signalling through Ca(2+)/PKC-alpha-dependent mechanism
por: Spinelli, Chiara Carmela, et al.
Publicado: (2017)

Correction for: LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice
por: Malavolta, Marco, et al.
Publicado: (2019)

Predicting and Designing Epitope Ensemble Vaccines against HTLV-1
por: Alam, Saruar, et al.
Publicado: (2020)

Characterization of the Phase-Variable Autotransporter Lav Reveals a Role in Host Cell Adherence and Biofilm Formation in Nontypeable Haemophilus influenzae
por: Phillips, Zachary N., et al.
Publicado: (2022)

Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2
por: Rende, Francesca, et al.
Publicado: (2012)

Heterogeneous loss of HIV transcription and proviral DNA from 8E5/LAV lymphoblastic leukemia cells revealed by RNA FISH:FLOW analyses
por: Wilburn, Kaley M., et al.
Publicado: (2016)

Peptide fragments immunoreactive with HTLV-III virus (HIV virus) antibody obtained by expressing cloned fragmented HTLV-II provirus nucleotide sequences; vaccine production etc.
Publicado: (1988)

Antiviral Strategies Against Chikungunya Virus
por: Abdelnabi, Rana, et al.
Publicado: (2015)

Association between 2D echocardiographic right atrial volume to left atrial volume (RAV/LAV) ratio and in-hospital prognosis in thrombolysed acute pulmonary thromboembolism patients
por: Kiran, G. Ravi, et al.
Publicado: (2020)

A role for an HTLV-1 vaccine?
por: Ratner, Lee
Publicado: (2022)

Antiviral Strategies against Arthritogenic Alphaviruses
por: Abdelnabi, Rana, et al.
Publicado: (2020)

Antivirals and antiviral strategies
por: Clercq, Erik De
Publicado: (2004)

Strategies to develop antivirals against enterovirus 71
por: Kuo, Rei-Lin, et al.
Publicado: (2013)

Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases
por: Kassay, Norbert, et al.
Publicado: (2021)

Comparative virology of HTLV-1 and HTLV-2
por: Martinez, Michael P., et al.
Publicado: (2019)

Fine tuning of the temporal expression of HTLV-1 and HTLV-2
por: Cavallari, Ilaria, et al.
Publicado: (2013)

Cancer vaccines
por: Dalgleish, A G
Publicado: (2000)

Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2019)

Preventive and Therapeutic Strategies for Bovine Leukemia Virus: Lessons for HTLV
por: Rodríguez, Sabrina M., et al.
Publicado: (2011)

Milk Transmission of HTLV-1 and the Need for Innovative Prevention Strategies
por: Millen, Sebastian, et al.
Publicado: (2022)

Evaluation of antibody frequency against HBV, HCV and HTLV-1
por: Tahaei, Seyed Mohammad Ebrahim, et al.
Publicado: (2012)

HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
por: Miyazato, Paola, et al.
Publicado: (2019)

Antiviral Strategies
por: Müller, B., et al.
Publicado: (2009)

Editorial: Pathogenesis, vaccines, and antivirals against respiratory viruses
por: Caceres, C. Joaquin, et al.
Publicado: (2023)

HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties
por: Ciminale, Vincenzo, et al.
Publicado: (2014)

The discovery of the first human retrovirus: HTLV-1 and HTLV-2
por: Gallo, Robert C
Publicado: (2005)

Subtype Analysis of HTLV‐1 in Patients with HTLV‐1 Uveitis
por: Ono, Ayako, et al.
Publicado: (1994)

Vertical Transmission of HTLV‐1 in HTLV‐1 Carrier Rat
por: Ami, Yoshihiro, et al.
Publicado: (1992)

Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years
por: Santana, Carolina Souza, et al.
Publicado: (2023)

Drug Delivery Strategies for Antivirals against Hepatitis B Virus
por: Singh, Latavia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vd707m5pavrl4baki0r2lbds66